Abstract. Desipramine HCI, IO mg/kg i.p. twice daily, produced subsensitivity to the hypothermic effects of nicotine,
The effects of antidepressants on nicotinic mechanisms have received minimal attention. Shaker et al. (1981) and Schofield et al. (198 I) presented evidence that tricyclic antidepressants bind to sites on the ionic channel of the nicotinic receptor (nAchR). We studied the effects of fluoxetine, phenelzinc, amitriptyline, lithium, and bright artificial light on a nicotinic mechanism involved in the regulation of core temperature in rats (Dilsaver and Hariharan, in press) .
We now report the effects of desipramine HCI (DM I) on this mechanism.
Methods
This report includes three experiments involving adult male Sprague-Dawley rats. Experiment I involves the measurement of change in core temperature in response to nicotine (base), I mg/ kg i.p., before and after I and 2 weeks of treatment with DMI, IO mg/kg i.p., at 9 a.m. and 5 p.m. in I2 rats with a mean weight of 319.2 (SD 46.1) g. Experiment 2 was a study of the effects of DMI on the disposition of nicotine in two
105
samples of IO rats each. The first group was treated with DMI, IO mg/kg i.p., at 9 a.m. and 5 p.m. for I4 days. The mean weight of this sample was 236.5 (SD 32.9) g. The second sample received saline injections, I mg/kg i.p., at 9 a.m. and 5 p.m. for I4 days. The mean weight of this sample was 288.0 (SD 13.3) g. Experiment 3 was a control experiment in which eight animals with a mean weight of 303 (SD 29.7) g were challenged with nicotine (base), I mg/ kg i.p., every 7 days for 3 weeks. The mean hypothermic response to nicotine was measured after the first and fourth injections.
The objective was to demonstrate that multiple injections of nicotine at the dose used in Experiment I do not produce subsensitivity to nicotine. The mobile phase is a citrate-phosphate buffer mixture (0.03 M each) with a final pH of 5.0, and containing 7% acetonitrile and 2 mM solidum hepatanesulphonate.
Measurement of
A C-18 Shandon column (Keystone Co., State College, PA) with a length of I50 mm and a diameter of 2 mm is used. The analytes are extracted from alkalinized plasma using methylene chloride. After separation, the organic solvent is evaporated using nitrogen gas. The residue is reconstituted with 50~1 of mobile phase, and 20 PI is injected into the column.
The sensitivity of the assay is I ng/ ml for nicotine and 2 ng/ ml for cotinine. The method is linear from 0 to 600 ng/ml for both analytes. The precision of the assay is 5% (coefficient of variation) (n = 30) for both substances (Hariharan et al., 1987) .
Pharmaceuticals.
DMI HCI and nicotine (base) were purchased from Sigma Chemical Company (St. Louis, MO). Doses of DMI and nicotine refer to the salt and base forms, respectively.
Both agents were administered i.p. on an mg/ kg basis.
Experimental
Design-Study 1. This study was divided into two phases. In Phase I, the thermosensors were implanted into I2 animals, which were allowed a minimum of 5 days to recover. During Phase 2, the hypothermic response to normal saline, I mg/ kg i.p., was measured. This provides a baseline taking into account the effects of handling and "placebo" injection. The thermic response to nicotine, I mg/kg i.p., was subsequently measured. The animals then received twice-daily injections (at 9 a.m. and 5 p.m.) of DMI, IO mg/ kg i.p. Twenty hours after the 14th and 28th doses of DMI, the animals were rechallenged with nicotine.
Experimental Design-Study 2. Ten animals were treated with DMI for I4 days. The animals were then injected with nicotine, I mg/ kg i.p., between 0930h and I230h. They were anesthetized with diethyl ether, and 30 min after the injection of nicotine, blood was drawn by cardiac puncture for the determination of plasma nicotine and cotinine levels. These levels were compared to those in the IO animals treated with saline.
Experimental Design-Study 3. Thermosensors were implanted into eight rats, which were allowed 5 days to recover before experimentation began. The sample then received nicotine, I mg/ kg i.p., every 7 days for 21 days. The thermic response to this drug was measured every IO min for I20 min following the first and fourth injections of nicotine.
Statistical
Analysis. Data from Experiments I and 3 were derived by calculating the mean thermic response across weeks for each rat. Mean temperature change between the challenges for each animal was then used to determine the significance of the mean change in temperature for the sample using Student's paired I test. The significance of the differences in the mean plasma nicotine and cotinine levels in Experiment 2 was determined using Student's two-sampled t test.
Measures of variance refer to the SD.
Results

Experiment 1.
Mean core temperature of this sample before the first experimental manipulation was 37.1 f 0.45"C. Table I  summarizes the results of this experiment. The thermic response to nicotine between I and 2 weeks of treatment did not differ (I = 0.88, df= I I; p > 0.35). Experiment 2. The mean nicotine levels in the experimental and control groups were 318.2 (SD 32.9) and 220.3 (SD 48.5) ng/ml, respectively (1 = 5.57, df= 18, p < 0.00003).
The mean cotinine levels were 87.0 (SD 35.0) and 232. I (SD 81.9) ng/ml, respectively (t = 5.22, df = 18, p < 0.000006). Thus, treatment with DMI was associated with highly elevated levels of plasma nicotine. The elevated levels of cotinine in the control sample relative to the experimental group suggest that DMI retarded the metabolism of nicotine.
Experiment 3. The mean hypothermic response to nicotine, I mg/ kg i.p., was -I .37 (SD 0.23)"C when the sample was first challenged, and -1.32 (SD 0.2O)"C at the time of the fourth challenge (f = 0.67, df = 7, p > 0.50). Thus, multiple injections of nicotine did not produce subsensitivity to subsequent challenges.
Discussion
Treatment with DMI produced subsensitivity to nicotine.
This effect was not due to a pharmacokinetic factor. Indeed, the DMI sample had a level of plasma nicotine that was 44% higher than that of the saline sample (p < 0.00003). Further, the saline sample had a much lower mean ratio of plasma nicotine to cotinine, I.0 (SD 0.09) as opposed to 4.0 (SD 0.39) by nicotine and potassium chloride from rat brain slices. In: Usdin, E., and Snyder, S.H., eds.
Frontiers of Catecholamine
Research. Pergamon Press, New York, p. 617 (1973) .
